AI-generated summary
The authors studied low level laser therapy applied to the skin of mice with lipopolysaccharide-induced acute respiratory distress syndrome, comparing lung and whole-body inflammation markers. They report reduced inflammatory cells and cytokines in lung fluid and serum in treated mice. The study used an animal model, so its relevance to humans is uncertain.
- Who or what was studied
- BALB/c mice with LPS-induced acute respiratory distress syndrome (pulmonary and extrapulmonary models)
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study used a mouse model with small groups (6 to 9 animals per group), so findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830nm
- Power
- 35mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.